Qualitative Assessment of Contrast-Enhanced Ultrasound in Differentiating Clear Cell Renal Cell Carcinoma and Oncocytoma
Authors:
- Antonio TufanoATAntonio Tufano
- Costantino LeonardoCLCostantino Leonardo
- Chiara Di BellaCBChiara Di Bella
- Giuseppe LucarelliGLGiuseppe Lucarelli
- Vincenzo DolcettiVDVincenzo Dolcetti
- Piervito DipintoPDPiervito Dipinto
- Flavia ProiettiFPFlavia Proietti
- Rocco Simone FlammiaRFRocco Simone Flammia
- Umberto AnceschiUmberto Anceschi
- Sisto PerdonàSisto Perdonà
- Giorgio FrancoGFGiorgio Franco
- Alessandro SciarraASAlessandro Sciarra
Open Access
- 23 April 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (9) , 3070
Abstract
Background: We aimed to assess whether clear cell renal cell carcinoma (ccRCC) can be differentiated from renal oncocytoma (RO) on a contrast-enhanced ultrasound (CEUS). Methods: Between January 2021 and October 2022, we retrospectively queried and analyzed our prospectively maintained dataset. Renal mass features were scrutinized with conventional ultrasound imaging (CUS) and CEUS. All lesions were confirmed by histopathologic diagnoses after nephron-sparing surgery (NSS). A multivariable analysis was performed to identify the potential predictors of ccRCC. The area under the curve (AUC) was depicted in order to assess the diagnostic accuracy of the multivariable model. Results: A total of 126 renal masses, including 103 (81.7%) ccRCC and 23 (18.3%) RO, matched our inclusion criteria. Among these two groups, we found significant differences in terms of enhancement (homogeneous vs. heterogeneous) (p < 0.001), wash-in (fast vs. synchronous/slow) (p = 0.004), wash-out (fast vs. synchronous/slow) (p = 0.001), and rim-like enhancement (p < 0.001). On the multivariate logistic regression, heterogeneous enhancement (OR: 19.37; p = p = 0.049) were independent predictors of ccRCC. Finally, these two variables had an AUC of 82.5% and 75.3%, respectively. Conclusions: Diagnostic imaging for presurgical planning is crucial in the choice of either conservative or radical management. CEUS, with its unique features, revealed its usefulness in differentiating ccRCC from RO.Keywords
This publication has 35 references indexed in Scilit:
- Pathology and Genetics: Tumours of the Urinary System and Male Genital SystemEuropean Urology, 2016
- Contrast-enhanced ultrasound (CEUS) of cystic and solid renal lesions: a reviewAbdominal Radiology, 2015
- The diagnostic value of contrast-enhanced ultrasound in differentiating small renal carcinoma and angiomyolipomaBioScience Trends, 2015
- Systematic Review of Perioperative and Quality-of-life Outcomes Following Surgical Management of Localised Renal CancerEuropean Urology, 2012
- The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathologyWorld Journal of Urology, 2011
- Contrast enhanced ultrasound of renal massesWorld Journal of Radiology, 2010
- Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasmsClinical Radiology, 2009
- Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumorsDiagnostic Pathology, 2008
- The application of ultrasound contrast agents in the characterization of renal tumorsWorld Journal of Urology, 2004
- Contrast-Enhanced Second-Harmonic Sonography in the Detection of Pseudocapsule in Renal Cell CarcinomaAmerican Journal of Roentgenology, 2004